James Hall
Amministratore Delegato presso Betagenon Sweden AB
Profilo
James Hall is currently the Chief Executive Officer at Betagenon Sweden AB.
He received his undergraduate and doctorate degrees from the University of Oxford.
Posizioni attive di James Hall
| Società | Posizione | Inizio |
|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Amministratore Delegato | 27/05/2021 |
Formazione di James Hall
| University of Oxford | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
- Borsa valori
- Insiders
- James Hall
